Liver Diseases  >>  Nerlynx (neratinib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nerlynx (neratinib) / Puma
NCT00781430: Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease

Completed
1
27
RoW
Neratinib (HKI-272)
Puma Biotechnology, Inc.
Hepatic Insufficiency
02/10
02/10

Download Options